Inactive Instrument

Press Releases Anchiano Therapeutics Ltd.

Equities

ANCN

US03280X1028

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

ANCHIANO THERAPEUTICS LTD. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	21-03-17	AQ
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing	21-03-15	GL
ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K)	21-03-10	AQ
ANCHIANO THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	21-03-09	AQ
ANCHIANO THERAPEUTICS LTD. : Other Events (form 8-K)	21-02-08	AQ
ANCHIANO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Anchiano Therapeutics Ltd. - ANCN	21-01-16	BU
ANCHIANO THERAPEUTICS LTD. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	20-12-15	AQ
Anchiano Therapeutics : and Chemomab Announce Entry Into Definitive Merger Agreement	20-12-15	AQ
ANCHIANO THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-11-16	AQ
ANCHIANO THERAPEUTICS LTD. : Change in Directors or Principal Officers (form 8-K)	20-10-20	AQ
ANCHIANO THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-08-14	AQ
ANCHIANO THERAPEUTICS LTD. : Change in Directors or Principal Officers (form 8-K)	20-07-15	AQ
ANCHIANO THERAPEUTICS LTD. : Change in Directors or Principal Officers, Other Events (form 8-K)	20-07-09	AQ
Anchiano Therapeutics : Appoints Stan Polovets as Chairman of the Board	20-05-28	AQ
Anchiano Appoints Stan Polovets as Chairman of the Board	20-05-26	GL
ANCHIANO THERAPEUTICS LTD. : Change in Directors or Principal Officers (form 8-K)	20-05-21	AQ
Anchiano Therapeutics : APPOINTS STEVE DIPALMA AS CHIEF FINANCIAL OFFICER	20-05-18	PU
Anchiano Therapeutics Reports First Quarter 2020 Financial Results	20-05-11	GL
ANCHIANO THERAPEUTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	20-05-07	AQ
ANCHIANO THERAPEUTICS LTD. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	20-05-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Anchiano Therapeutics Ltd.

Equities

ANCN

US03280X1028

Press Releases

Filters